How TikTok parent is using AI to boost drug discovery
newsbytesapp.com May 3, 2026

How TikTok parent is using AI to boost drug discovery

AI-summarised brief · reviewed before publication

ByteDance, the parent company of TikTok, is making significant strides in the field of artificial intelligence (AI) with its dedicated drug-discovery unit, Anew Labs. The Shanghai-based division operates from three major locations and boasts a team of 36 core members, including industry veterans on its scientific advisory board. Anew Labs has been actively presenting its AI-developed therapies at international conferences, showcasing its commitment to innovative drug discovery through AI technology.

💡 Why It Matters

  • · The involvement of ByteDance in AI-driven drug discovery highlights the potential for technology giants to transform traditional industries.
  • · By leveraging AI, ByteDance may unlock new treatments for autoimmune diseases, underscoring the power of innovative collaborations between tech and healthcare.